SCHEMBL25832144

SCHEMBL25832144

Cc1cc2c(cc1O)OC[C@@H](C)CC2=O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX12 P18054 5/20 0.41
ALOX15 P16050 4/20 0.41
IMPDH2 P12268 1/20 0.38
IMPDH1 P20839 1/20 0.38
ALOX15B O15296 1/20 0.36
PBRM1 Q86U86 1/20 0.35
POLB P06746 2/20 0.35
CRHBP P24387 1/20 0.35
CRHR2 Q13324 1/20 0.35
ABCG2 Q9UNQ0 1/20 0.35
AR P10275 5/20 0.33
CYP3A4 P08684 2/20 0.33
KDM4E B2RXH2 1/20 0.33
ALDH1A1 P00352 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP2D6 P10635 1/20 0.33
MAPT P10636 1/20 0.33
G6PD P11413 1/20 0.33
CYP2C9 P11712 1/20 0.33
PKM P14618 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1430018 0.78 PSMB5 (0.41) ALOX12ALOX15IMPDH2IMPDH1POLB
SCHEMBL25832160 0.76 CYP19A1 (0.55) PBRM1KDM4EACHECYP19A1KMT2A
SCHEMBL7940690 0.76 MAOB (0.56) ALOX12ALOX15IMPDH2IMPDH1CYP3A4
SCHEMBL29756799 0.73 MAOB (0.45) ALOX12ALOX15IMPDH2IMPDH1POLB
SCHEMBL20165228 0.73 MAOB (0.45) ALOX12ALOX15IMPDH2IMPDH1POLB
SCHEMBL25832172 0.72 CYP19A1 (0.54) PBRM1ARALDH1A1MAPTPKM
SCHEMBL14741423 0.70 PBRM1 (0.53) PBRM1ARCYP19A1MAOB
SCHEMBL31546010 0.66 PTPN1 (0.41) ALOX12ALOX15ALOX15BCYP3A4CYP19A1
Hydrochloric Acid SCHEMBL11337948 0.66 IMPDH2 (0.44) ALOX12ALOX15IMPDH2IMPDH1PBRM1
SCHEMBL21360079 0.65 ALOX12 (0.35) ALOX12ALOX15ALOX15BPBRM1AR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11702427-B2 Substituted 2-pyridone tricyclic compounds, analogues thereof, and methods using same ARBUTUS BIOPHARMA CORPORATION (CA) 2023-07-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11702427-B2 Substituted 2-pyridone tricyclic compounds, analogues thereof, and methods using same HAVCR2, HPD, CYP24A1 ALOX12 2514/4885ALOX15 2204/4885IMPDH2 359/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.